Evaluating the feasibility and predictive accuracy of biodynamic imaging to platinum-based chemotherapy response in esophageal adenocarcinoma
BDI technology can potentially predict patients' response to platinum chemotherapy. Additionally, this technology represents a promising step towards optimizing treatment strategies for esophageal adenocarcinoma patients by pre-emptively identifying non-responders to conventional platinum-based chemotherapy.
Authors
- Susan M. Perkins (ORCID: https://orcid.org/0000-0002-5842-4354)
- Ali Ajrouch
- Mohammad Al‐Haddad (ORCID: https://orcid.org/0000-0003-1641-9976)
- John Turek (ORCID: https://orcid.org/0000-0003-4631-7356)
- Shadia I. Jalal (ORCID: https://orcid.org/0000-0001-8938-7077)
- Ahmad Karkash
- David D. Nolte (ORCID: https://orcid.org/0000-0002-4872-9357)
- Dawith Lim
- Ben Krempley
- John M. Dewitt
Institutions
- Indiana University Health (US)
- Purdue University West Lafayette (US)
- Indiana Cancer Consortium (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3389/fonc.2024.1429343
- Citations
- 4
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.29
Funders
- National Science Foundation
- Purdue University